A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin‐Zhi Qian, Jiufeng Li, Hui Zhang et al. · Nature · 2011 · 2.9K citations · Full text

Medicine, Cancer Biology, Oncology +14

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono, Howard I. Scher, Bruce Montgomery et al. · Clinical Cancer Research · 2008 · 2.2K citations

Medicine, Biostatistics, Oncology +17

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 984 citations

Medicine, Oncology, Genitourinary Oncology +16

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

Takayuki Ueno, Masakazu Toi, Hisashi Saji et al. · PubMed · 2000 · 711 citations

Life Sciences, Cancer Biology, Oncology +17